The UK Teratology Information Service (UKTIS), the MacDonald Obstetric Medicine Society (MOMS), and the British Maternal and Fetal Medicine Society (BMFMS) have issued a joint statement on the use of paracetamol during pregnancy and its possible association with autism spectrum disorder (ASD).
Paracetamol is one of the most commonly used medicines in pregnancy and is generally considered the drug of choice for managing pain and fever. A large number of studies have examined potential neurodevelopmental outcomes following in utero exposure to paracetamol, but results have been inconsistent.
A recent 2025 review of key epidemiological studies concluded that paracetamol use during pregnancy is unlikely to confer a clinically important increased risk of autism spectrum disorder. The evidence does not support any change to current clinical guidelines for the management of pain and fever in pregnancy.
The statement emphasises that effective treatment of maternal pain and fever is important for the health of both mother and baby. Untreated pain and fever can negatively affect maternal wellbeing and daily functioning, and may increase risks for the fetus, including miscarriage, growth restriction, malformation, and preterm birth.
Paracetamol remains the recommended treatment option during pregnancy. Other alternatives, such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, or gabapentinoids, are either associated with greater risks or lack sufficient safety data for use in pregnancy.
While some studies have suggested a possible link between prenatal paracetamol exposure and ASD, these have been limited by important methodological weaknesses, including selection bias and inadequate adjustment for genetic and familial factors known to influence ASD risk. Studies that control for these confounders, such as those using sibling comparisons, report much weaker or no associations.
The joint statement concludes that there is no good evidence that paracetamol use in pregnancy causes ASD, and that avoidance of paracetamol when clinically indicated could itself result in harm. Pregnant women who have concerns about paracetamol use are advised to discuss them with their healthcare professional.
Click here to view joint statement
About the contributors
Lucy Mackillop, President of the MacDonald Obstetric Medicine Society (MOMS) and Honorary Senior Clinical Lecturer at the Nuffield Department of Women’s and Reproductive Health, University of Oxford, contributed to this joint statement alongside colleagues from UKTIS and BMFMS.
Key references
- Damkier P, Gram EB, Ceulemans M, Panchaud A, Cleary B, Chambers C, Weber-Schoendorfer C, Kennedy D, Hodson K, Grant KS, Diav-Citrin O, Običan SG, Shechtman S, Alwan S. Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstet Gynecol. 2025 Feb 1;145(2):168-176. doi: 10.1097/AOG.0000000000005802. Epub 2024 Dec 5. PMID: 39637384.
- Alemany S, Avella-Garcia C, Liew Z, Garcia-Esteban R, Inoue K, Cadman T, et al. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts. European Journal of Epidemiology. 2021;36(10):993-1004.
- Masarwa R, Levine H, Gorelik E, Reif S, Perlman A, Matok I. Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies. American Journal of Epidemiology. 2018;187(8):1817-27.
- Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. International Journal of Epidemiology. 2013.
- Avella-Garcia CB, Julvez J, Fortuny J, Rebordosa C, Garcia-Esteban R, Galan IR, et al. Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. International Journal of Epidemiology. 2016;45(6):1987-96.
- Stergiakouli E, Thapar A, Davey Smith G. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding. JAMA Pediatr. 2016;170(10):964-70.
- Streissguth AP, Treder RP, Barr HM, Shepard TH, Bleyer WA, Sampson PD, et al. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987;35(2):211-9.
- Liew Z, Bach CC, Asarnow RF, Ritz B, Olsen J. Paracetamol use during pregnancy and attention and executive function in offspring at age 5 years. International Journal of Epidemiology. 2016;45(6):2009-17.
- Ahlqvist VH, Sjöqvist H, Dalman C, Karlsson H, Stephansson O, Johansson S, Magnusson C, Gardner RM, Lee BK. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024 Apr 9;331(14):1205-1214. doi: 10.1001/jama.2024.3172. PMID: 38592388; PMCID: PMC11004836.
- Gustavson K, Ystrom E, Ask H, Ask Torvik F, Hornig M, Susser E, Lipkin WI, Lupattelli A, Stoltenberg C, Magnus P, Mjaaland S, Askeland RB, Walle KM, Bresnahan M, Nordeng H, Reichborn-Kjennerud T. Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder – a longitudinal sibling control study. JCPP Adv. 2021 Jun 22;1(2):e12020. doi: 10.1002/jcv2.12020. PMID: 37431475; PMCID: PMC10242945.
- UK Teratology Information Service. Therapeutic use of paracetamol in pregnancy. 2023 (version 2.0). Available from: https://uktis.org/monographs/therapeutic-use-of-paracetamol-in-pregnancy/
- UK Teratology Information Service. Use of non-steroidal anti-inflammatory drugs (NSAIDs) in pregnancy. 2023 (version 4.0). Available from: https://uktis.org/monographs/use-of-non-steroidal-anti-inflammatory-drugsnsaids-in-pregnancy/
- UK Teratology Information Service. Pain management in pregnancy. 2019 (version 3.1). Available from: https://uktis.org/monographs/pain-management-in-pregnancy/